A Case Report of Antibiotic-Induced Aseptic Meningitis in Psoriasis
- PMID: 34195619
- PMCID: PMC8237324
A Case Report of Antibiotic-Induced Aseptic Meningitis in Psoriasis
Abstract
Although frequently prescribed, certain antibiotics such as trimethoprim-sulfamethoxazole carry the risk of a rare yet life-threatening adverse effect, termed drug-induced aseptic meningitis. Morbidity can be avoided if the medication is identified and discontinued. Patients in reported cases tend to be female and have an autoimmune disease or prior adverse reaction to the offending agent. As a rare and poorly characterized condition, the subset of patients using antibiotics at risk for aseptic meningitis remains unclear; hence, cataloging these adverse events remains critical for better elucidating the disease. Here, we report a 62-year-old man with psoriasis and no prior history of sulfa allergy, who presented with a sudden onset of fever, chills, vomiting, and muscle aches 5 hours after taking single doses of trimethoprim-sulfamethoxazole and ciprofloxacin. Common infectious causes were ruled out, and his medications were discontinued. Despite initial symptom resolution with discontinuation, the patient neurologically deteriorated over the next two days before eventually recovering with supportive care. This case highlights the variable presentation of drug-induced aseptic meningitis. In contrast to previous reports of drug-induced aseptic meningitis, our patient was male, older than the median age of 40 years, and did not have a prior adverse reaction to the antibiotic. Furthermore, to the best of our knowledge, we report a possible case of antibiotic-induced aseptic meningitis in a patient with psoriasis. Lastly, the case emphasizes not only the value of a thorough medication history but also the importance of recognizing that patients may deteriorate in the first 48 hours before resolution.
Keywords: TMP-SMX; Trimethoprim; adverse effect; aseptic meningitis; drug reaction; drug-induced; meningitis; sulfamethoxazole.
©Copyright 2021 by University Health Partners of Hawai‘i (UHP Hawai‘i).
Similar articles
-
Trimethoprim-sulfamethoxazole-induced aseptic meningitis.J Natl Med Assoc. 2005 Dec;97(12):1725-8. J Natl Med Assoc. 2005. PMID: 16396068 Free PMC article.
-
Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: a case report.BMC Pediatr. 2021 Aug 16;21(1):345. doi: 10.1186/s12887-021-02820-y. BMC Pediatr. 2021. PMID: 34399711 Free PMC article.
-
Possible trimethoprim/sulfamethoxazole-induced aseptic meningitis.Ann Pharmacother. 2004 Nov;38(11):1863-7. doi: 10.1345/aph.1D581. Epub 2004 Sep 14. Ann Pharmacother. 2004. PMID: 15367724
-
Trimethoprim-sulfamethoxazole-induced aseptic meningitis: case report and literature review.Intensive Care Med. 2000 Feb;26(2):212-4. doi: 10.1007/s001340050048. Intensive Care Med. 2000. PMID: 10784311 Review.
-
A case of recurrent trimethoprim-sulfamethoxazole-induced aseptic meningitis and review of literature.Int J Clin Pharmacol Ther. 2020 Sep;58(9):511-517. doi: 10.5414/CP203749. Int J Clin Pharmacol Ther. 2020. PMID: 32567546 Review.
Cited by
-
A Case of Trimethoprim-Sulfamethoxazole Associated Aseptic Meningitis.Clin Case Rep. 2025 Feb 19;13(2):e70244. doi: 10.1002/ccr3.70244. eCollection 2025 Feb. Clin Case Rep. 2025. PMID: 39980891 Free PMC article.
-
Emerging Contaminants: An Important But Ignored Risk Factor for Psoriasis.Clin Rev Allergy Immunol. 2025 Mar 23;68(1):33. doi: 10.1007/s12016-025-09043-4. Clin Rev Allergy Immunol. 2025. PMID: 40121604 Review.